D-0753-2021 Class II Terminated

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0753-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Aug 13, 2021 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle The recall status is terminated (terminated Apr 3, 2023). Affected quantity: 2880 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 25, 2021
Initiation Date
Aug 13, 2021
Termination Date
Apr 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2880 bottles

Product description

Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05

Reason for recall

Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

Distribution pattern

Nationwide in the US

Code information

Z006279, exp 12/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0753-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0753-2021. Report a data issue: hello@regdatalab.com.